Pluri Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Pluri Inc. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $32.00K.
- Pluri Inc. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $2.00K, a 99.98% decline year-over-year.
- Pluri Inc. stock issued during period, value, new issues for the quarter ending 2025-12-31 was $46.00K.
- Pluri Inc. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $0.00.
- Pluri Inc. stock issued during period, value, new issues for fiscal 2026 was $80.00K, a 97.93% decline from fiscal 2025.
- Pluri Inc. stock issued during period, value, new issues for fiscal 2025 was $3.87M, a 4156.04% increase from fiscal 2024.
- Pluri Inc. stock issued during period, value, new issues for fiscal 2024 was $91.00K.
- Pluri Inc. stock issued during period, value, new issues for fiscal 2018 was $4.99M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-10 | $80.00K 10-K · filed 2026-09-10 |
| 2026-03-31 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-14 | -$5.32M derived: sum of 4 quarters · filed 2026-09-10 |
| 2025-12-31 | $46.00K 10-Q · filed 2026-02-12 | $3.92M derived: sum of 4 quarters · filed 2026-09-10 |
| 2025-09-30 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2026-09-10 | |
| 2025-06-30 | -$5.37M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-17 | $3.87M 10-K · filed 2025-09-17 |
| 2025-03-31 | $9.24M 10-Q · filed 2025-05-13 | |
| 2024-06-30 | $91.00K 10-K · filed 2024-09-18 | |
| 2018-06-30 | $2.57M derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-12 | $4.99M 10-K · filed 2018-09-12 |
| 2018-03-31 | $1.39M 10-Q · filed 2019-05-06 | |
| 2017-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-06 | |
| 2017-09-30 | $1.03M 10-Q · filed 2018-11-07 | |
| 2015-06-30 | $15.80M 10-K · filed 2017-09-07 | |
| 2014-06-30 | $495.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-09 | $10.64M 10-K · filed 2015-09-09 |
| 2013-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-09 | $34.11M 10-K · filed 2015-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |